With multilayered deal, GSK and Novartis play to their strengths

Featured Story

With multilayered deal, GSK and Novartis play to their strengths

April 22, 2014 11:23 am by | 0 Comments

It’s all change with Big Pharma this week. A series of deals between GlaxoSmithKline (NYSE: GSK) and Novartis has reshaped both businesses in a move that will shift GSK away…


Allergan said it will ‘carefully consider’ buyout offer from Valeant

Allergan said it will ‘carefully consider’ buyout offer from Valeant

April 22, 2014 9:00 pm by | 0 Comments

Allergan Inc., the Irvine company that makes popular wrinkle treatment Botox, acknowledged Tuesday that it has received a buyout offer from Valeant Pharmaceuticals International Inc. The company said the offer…


Maker of Botox wrinkle treatment attracts $45.6B bid from activist investor Ackman and Valeant Pharma

Maker of Botox wrinkle treatment attracts $45.6B bid from activist investor Ackman and Valeant Pharma

April 22, 2014 12:26 pm by | 0 Comments

Activist investor Bill Ackman and his unlikely Canadian partner, Valeant Pharmaceuticals International Inc., unveiled details of their bid for Irvine pharmaceutical company Allergan Inc., which makes the popular Botox wrinkle…



ProNAi raises $60 million to advance treatment to combat lymphoma

ProNAi raises $60 million to advance treatment to combat lymphoma

April 21, 2014 6:16 pm by | 0 Comments

Cancer drug developer ProNAi Therapeutics, which developed a nucleic acid-based DNA-interference technology to cause cancer cell death, has added nine new investors in an oversubscribed Series D round. The latest…


Building a new product for doctors? An MD/VC has some advice for winning over early adopters

Building a new product for doctors? An MD/VC has some advice for winning over early adopters

April 21, 2014 12:02 pm by | 0 Comments

Dr. Akhil Saklecha has seen many a startup stumble over the process of getting physician adoption of new technology. If a company fails to get physicians on board early in…


Amidst Gilead’s Hepatitis C pill patent debate in India, concerns about access to breakthrough drug

Amidst Gilead’s Hepatitis C pill patent debate in India, concerns about access to breakthrough drug

April 21, 2014 10:42 am by | 0 Comments

A cure for hepatitis C might seem like welcome news in India, where 12 million people suffer from the disease. But the country isn’t quite rolling out the red carpet…


Here are five different approaches to crowdfunding for biotechnology

Here are five different approaches to crowdfunding for biotechnology

April 21, 2014 8:19 am by | 1 Comments

The impact of federal budget cuts compounded by the challenges of securing funding for biotechnology companies has led to a growing trend of drug development. Scientists are turning to crowdfunding…


Four old meds leading the price spike among generics: doxycycline, albuterol, clomipramine, and captopril

Four old meds leading the price spike among generics: doxycycline, albuterol, clomipramine, and captopril

April 21, 2014 4:00 am by | 0 Comments

Pharmacist Larry Cowan can flip through his records and spot the generic drugs that have taken big price jumps in the past year or so.
There’s digoxin, a heart medicine that he used to buy for pennies a pill.
“Now the price is close to 10 times that,” …



Too many children’s emergency room visits result in codeine prescriptions

Too many children’s emergency room visits result in codeine prescriptions

April 21, 2014 12:38 am by | 0 Comments

CHICAGO (AP) — Despite recommended limits on codeine use in children, the potent painkiller is prescribed for children in at least half a million emergency room visits each year, a…


Google hires UCSF geneticist who figured out how to stop aging in roundworms

Google hires UCSF geneticist who figured out how to stop aging in roundworms

April 20, 2014 5:22 am by | 0 Comments

Google’s mysterious health venture dedicated to extending human life has quietly lured a prominent scientist away from UCSF, The Chronicle has learned.
The university confirmed that Cynthia Kenyon, a biochemistry and biophysics professor acclaimed for …


Mobile health apps from EHR to diabetes picked as Webby award honorees

Mobile health apps from EHR to diabetes picked as Webby award honorees

April 18, 2014 5:54 pm by | 0 Comments

As part of the annual Webby Awards this year,  11 mobile health apps were chosen as honorees. They include behavioral health apps from the Veteran’s Administration, a diabetes app from…


Opko acquires early stage digital inhaler device co. to pair it with respiratory drugs

Opko acquires early stage digital inhaler device co. to pair it with respiratory drugs

April 17, 2014 3:00 pm by | 0 Comments

As pharmaceutical companies look for ways to add value to their drugs to solve problems like adherence, many see digital health as an important part of that strategy. Respiratory drug…


ASCO at work on a scoring system to weigh cost vs. potential benefits of pricey cancer treatments

ASCO at work on a scoring system to weigh cost vs. potential benefits of pricey cancer treatments

April 17, 2014 12:03 pm by | 0 Comments

Cancer doctors and patients need a better way to weigh the potential benefits of new targeted cancer treatments against their costs, especially those that carry a price tag north of…


Google pitches pharma on YouTube merits for DtC advertising

Google pitches pharma on YouTube merits for DtC advertising

April 17, 2014 11:38 am by | 0 Comments

The pharmaceutical industry is warming up to direct to consumer advertising on YouTube, but Google, which acquired the media channel in 2006, would like drug companies to get a lot warmer.


Space institute funds eye tracking to detect brain injury, drugs + apps platform

Space institute funds eye tracking to detect brain injury, drugs + apps platform

April 17, 2014 6:00 am by | 1 Comments

The National Space Biomedical Research Institute in Houston said it’s provided funding to two promising early-stage technologies that take novel approaches to problems both on earth and in space. First…


Zogenix prevails in initial challenge to Massachusetts emergency order banning ZOHYDRO ER

Zogenix prevails in initial challenge to Massachusetts emergency order banning ZOHYDRO ER

April 17, 2014 12:59 am by | 0 Comments

 By Kurt R. Karst –   When we first heard about the Complaint and Motion for Preliminary Injunction Zogenix, Inc. filed against Massachusetts Governor Deval Patrick, among others, alleging that…